Sepio Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Sepio Capital's LLY Position: Q1 2026 in Review
Sepio Capital reduced its Eli Lilly (LLY) stake by 7.6% in Q1 2026, selling an estimated $64.9K and leaving 781 shares worth $718K. The position accounts for 0.04% of the portfolio, ranked #211.
Sepio Capital first reported a position in LLY in Q2 2022 and has held it in 8 quarters since. The position peaked at $908K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Sepio Capital held 781 shares of Eli Lilly worth $718K as of Q1 2026.
- Sepio Capital sold 64 Eli Lilly shares in Q1 2026, an estimated $64.9K.
- Eli Lilly made up 0.04% of Sepio Capital's portfolio in Q1 2026, its #211 holding.
- Sepio Capital first reported a position in Eli Lilly in Q2 2022 and has held it in 8 quarters since.
- Sepio Capital's Eli Lilly position peaked at $908K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Sepio Capital's 13F filing for Q1 2026, filed 13 May 2026.